Skip to main content
. Author manuscript; available in PMC: 2014 Jul 14.
Published in final edited form as: Growth Factors. 1997;15(1):1–27. doi: 10.3109/08977199709002109

TABLE I.

Distribution of Cell Phenotypes in C2 Cultures Reacted via Double Immunofluorescence with Antibodies Against MyoD and Myogenin

Averaged Per Ten Fieldsa
Days
in 2%
FCS
Growth
Factor
Added
Total
Number
of Cells
Number
of Cells
Fused
into
Myotubes
Mononucleated Cells Only
Total Number
of Cells with
Myogenic
Phenotypeb
All MyoD+ All Myog+ MyoD+/Myog− MyoD+/Myog+ MyoD−/Myog+
1 None
PDGF
1049.2 ± 135.2
980.7 ± 103.2
0.5 ± 0.5
0
107.2 ± 14.2
100.7 ± 17.7
28 ± 6
18.5 ± 4
79.2 ± 8.2
82.2 ± 13.7
28 ± 6
18 ± 4.5
0
0.5 ± 0.5
107.7 ± 14.7
100.7 ± 17.7
2 None
PDGF
1074.5 ± 73.5
2314.5 ± 224.5
41 ± 29
6 ± 2
191.5 ± 0.5
228.5 ± 2.5
170 ± 6
180 ± 13
75.5 ± 8.5
115.5 ± 6.5
116 ± 9
113 ± 9
54 ± 3
67 ± 4
286.5 ± 26.5
301.5 ± 4.5
3 None
PDGF
1224.5 ± 85.5
2932.5 ± 119.5
80.5 ± 20.5
40.5 ± 2.5
276 ± 41
324 ± 24
246 ± 18
275 ± 65
71.5 ± 13.5
139.5 ± 8.5
204.5 ± 27.5
184.5 ± 15.5
41.5 ± 9.5
90.5 ± 47.5
398 ± 1
455 ± 76
4 None
PDGF
1292.5 ± 2.5
3468.5 ± 151.5
263.5 ± 15.5
143.5 ± 29.5
139 ± 45
402.5 ± 46.5
178 ± 6
402.5 ± 42.5
58 ± 23
202.5 ± 45.5
81 ± 22
200 ± 1
97 ± 16
202.5 ± 43.5
499.5 ± 13.5
751.5 ± 23.5
a

Cultures were initiated at higher cell density in proliferation medium and 24 hours later switched to 2% FCS ( ± PDGF-BB). Results shown for days 2 through 5 under all categories reflect the actual numbers scored for ten microscopic fields which were further averaged for duplicate plates. Scores for day 1 were obtained by analyzing twenty fields per plate and numbers were then averaged per ten fields using results of duplicate plates. Additional fields were analyzed for day 1 in order to more reliably measure the myogenin+ cells which were infrequent in the day 1 plates. Microscopic fields were randomly selected and counted using 40x objective.

b

The total number of cells with a ‘myogenic phenotype’ is the sum of the number of cells under: MyoD+/myogenin−, MyoD+/myogenin+. MyoD−/myogenin+, and cells fused into myobtubes.